Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use (AIM-STOP)
Anchoring Intermittent Long Acting Antimicrobials to Medication for Opioid Use Disorder Treatment to Facilitate Structured Transitions of Care for People Who Use Drugs Admitted to the Hospital With Invasive Infections
Sponsor: University of Maryland, Baltimore
Terminated
The study was not able to enroll adequate participants within predetermined timelines
Other terminated trials from University of Maryland, Baltimore
Other Bacteremia trials with similar outcome
Listed as NCT05521880, this PHASE4 trial focuses on Bacteremia and Infection, Soft Tissue and remains terminated or withdrawn. Sponsored by University of Maryland, Baltimore, it has been updated 12 times since 2024, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Jun 2025 — Present [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Dec 2024 — Jun 2025 [monthly]
Recruiting PHASE4
-
Sep 2024 — Dec 2024 [monthly]
Recruiting PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Not Yet Recruiting PHASE4
▶ Show 7 earlier versions
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE4
-
Mar 2024 — May 2024 [monthly]
Not Yet Recruiting PHASE4
-
Dec 2023 — Mar 2024 [monthly]
Not Yet Recruiting PHASE4
-
Oct 2023 — Dec 2023 [monthly]
Not Yet Recruiting PHASE4
-
Jul 2023 — Oct 2023 [monthly]
Not Yet Recruiting PHASE4
-
Apr 2023 — Jul 2023 [monthly]
Not Yet Recruiting PHASE4
-
Sep 2022 — Apr 2023 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .